Filter
327
Text search:
recall
of
medicines
Featured
Recommendations
27
New Publications
111
Language
Document type
No document type
189
Guidelines
43
Studies & Reports
36
Manuals
28
Training Material
18
Strategic & Response Plan
8
Fact sheets
3
Situation Updates
1
Online Courses
1
Countries / Regions
India
29
Kenya
18
Nepal
13
South Africa
12
Global
12
Zambia
10
Uganda
9
Ghana
8
Malawi
8
Ethiopia
7
Philippines
7
Namibia
7
Nigeria
5
Rwanda
5
Bangladesh
5
South–East Asia Region
5
Myanmar / Burma
4
Liberia
3
Zimbabwe
3
Tanzania
3
Middle East and North Africa
3
Africa
3
Sierra Leone
2
Senegal
2
Haiti
2
Syria
2
Sudan
2
Botswana
2
Asia
2
Venezuela
2
Cameroon
1
Lebanon
1
Cambodia
1
Thailand
1
China
1
Indonesia
1
Ukraine
1
Lesotho
1
Yemen
1
Western Pacific Region
1
Latin America and the Carribbean
1
Western and Central Europe
1
Mongolia
1
Southern Africa
1
Canada
1
Timor Leste/ East Timor
1
Australia
1
Vietnam
1
United Kingdom
1
Authors & Publishers
Publication Years
Category
Countries
158
Public Health
27
Clinical Guidelines
20
Capacity Building
19
Women & Child Health
18
Key Resources
9
Pharmacy & Technologies
3
Toolboxes
Pharmacy
26
Mental Health
21
HIV
19
Caregiver
17
COVID-19
16
NCDs
15
TB
10
Malaria
9
Disability
8
AMR
7
Global Health Education
6
Health Financing Toolbox
4
Ebola & Marburg
3
Conflict
3
2.0 Rapid Response
3
Natural Hazards
2
Rapid Response
2
Refugee
2
Zika
2
NTDs
2
Cholera
1
Polio
1
Specific Hazards
1
PMPB/INS-GUIDE/02
This field study to measure access to and use of medicines was undertaken in GHANA in May-June 2008. The study assessed information on the socio-economic level
...
Medicines and Allied Substances [No. 3 of 2013 47 | An Act to continue the existence of the Pharmaceutical Regulatory Authority and re-name it as t
...
Therapeutics Information and Pharmacovigilance Centre | TIPC
This guidance should be followed if an unlicensed medicine is prepared in
a registered pharmacy. The preparation of an unlicensed medicine (for
example unlicensed methadone, or menthol in aqueous cream) in a pharmacy is called ‘extemporaneous
...
Submitted to the US Agency for International Development by the
Systems for Improved Access to Pharmaceuticals and Services (SIAPS) Program.
This manual provides a framework to identify problems and design interventions to improve access to and use of
...
Monitoring financial protection and utilization of health services in Mongolia 2009-2018 is based on national representative household socioeconomic surveys. The study finds that between 2009 and 2018, despite ambitious health reforms, the incidence
...
The Access to Controlled Medications Programme identified the development of treatment guidelines that cover the treatment of all types of pain as
...
WHO Technical Report Series, No. 961, 2011, Annex 8 - These guidelines are intended to provide a description of ways in which pharmacists can improve access to health care, health promotion and the use of
...
The Zimbabwe National Pharmacovigilance Policy Handbook, 2nd Edition updates the November 2013 version to indicate the Zimbabwe National Pharmacovigilance (PV) Centre’s compliance with the WHO Pharmacovigilance Indicators Handbook 2015.
The Ideal Clinic Realisation and Maintenance (ICRM) programme was initiated by the National Department of Health in July 2013 in order to systematically improve primary health care (PHC) facilities and the quality
...
Licensed pharmaceutical products (marketing authorization) should be manufactured only by licensed manufacturers (holders of a manufacturing authorization) whose activities are regularly inspected by competent national authorities. This guide to GMP
...
